The influence of the oncogene N-ras on cell cycle delay in a human melanoma cell line with reduced radioresistance

Oncology Reports

Volumn 7, Issue 3, 2000, Pages 663-667

  Pomp, J ^a,b,c   Ouwerkerk, I J M ^a   Hoogstraten, C ^a   Wondergem, J ^a   Davelaar, J ^a   Leer, J W H ^a   Schrier, P I ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c NONE   (Netherlands)

Author keywords

Flow cytometry; Human melanoma; Radiotherapy; Relative movement

Indexed keywords

KANAMYCIN KINASE;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIVISION; GENETIC TRANSFECTION; HUMAN; MELANOMA; MITOSIS; MUTAGENESIS; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; REPORTER GENE;

CELL CYCLE; CELL DIVISION; G2 PHASE; GENES, RAS; GENES, REPORTER; HUMANS; KANAMYCIN KINASE; MELANOMA; MITOSIS; MUTAGENESIS; RADIATION TOLERANCE; S PHASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034182666     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.3.663     Document Type: Article

References (37)

1. McKenna WG, Weiss MC, Bakanauskas VJ, Sandler H, Kelsten ML, Biaglow J, Tuttle SW, Endlich B, Ling CC and Muschel RJ: The role of the H-ras oncogene in radiation resistance and metastasis. Int J Radiat Oncol Biol Phys 18: 849-859, 1990.
2. Hermens AF and Bentvelzen PA: Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line. Cancer Res 52: 3073-3082, 1992.
3. Sklar MD: The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239: 645-647, 1988.
4. Ling CC and Endlich B: Radioresistance induced by oncogenic transformation. Radiat Res 120: 267-279, 1989.
5. Alapetite C, Baroche C, Remvikos Y, Goubin G and Moustacchi E: Studies on the influence of the presence of an activated ras oncogene on the in vitro radiosensitivity of human mammary epithelial cells. Int J Radiat Biol 59: 385-396, 1991.
6. Mendonca MS, Boukamp P, Stanbridge EJ and Redpath JL: The radiosensitivity of human keratinocytes: influence of activated cH-ras oncogene expression and tumorigenicity. Int J Radiat Biol 59: 1195-1206, 1991.
7. Pomp J, Ouwerkerk IJM, Hermans J, Wondergem J, Cornelisse CJ, Leer JWH and Schrier PI: The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line. Radiat Res 146: 374-381, 1996.
8. McKenna WG, Iliakis G, Weiss MC, Bernhard EJ and Muschel RJ: Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat Res 125: 283-287, 1991.
9. Su LN and Little JB: Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen. Radiat Res 133: 73-79, 1993.
10. Versteeg R, Noordermeer IA, Krüse-Wolters KM, Ruiter DJ and Schrier PI: c-Myc downregulates class I HLA expression in human melanomas. EMBO J 7: 1023-1029, 1988.
11. Van't Veer LJ, Burgering BMT, Versteeg R, Boot AJM, Ruiter DJ, Osanto S, Schrier PI and Bos JL: N-ras mutations in human cutaneous melanoma on sun-exposed body sites. Mol Cell Biol 9: 3114-3116, 1989.
12. Schrier PI: Melanoma genetics and cytogenetics. Clin Dermatol 10: 31-39, 1992.
13. Aubert C, Rouge F and Galindo JR: Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro. J Natl Cancer Inst 64: 1029-1040, 1980.
14. Van Elsas A, Van Deursen E, Wielders R, van den Berg-Bakker CA and Schrier PI: Ras oncogene activation does not induce sensitivity to natural killer cell-mediated lysis in human melanoma. J Invest Dermatol 103: 117S-121S, 1994.
15. Schrier PI, Versteeg R, Peltenburg LTC, Plomp AC, Van't Veer LJ and Krüse-Wolters KM: Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA expression? Semin Cancer Biol 2: 73-83, 1991.
16. Begg AC, McNally NJ, Shrieve DC and Karcher H: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626, 1985.
17. Samid D, Miller AC, Rimoldi D, Gafner J and Clark EP: Increased radiation resistance in transformed and non-transformed cells with elevated ras proto-oncogene expression. Radiat Res 126: 244-250, 1991.
18. McKenna WG, Weiss MC, Endlich B, Ling CC, Bakanauskas VJ, Kelsten ML and Muschel RJ: Synergistic effect of the v-myc oncogene with H-ras on radioresistance. Cancer Res 50: 97-102, 1990.
19. Maity A, McKenna WG and Muschel RJ: The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 31: 1-13, 1994.
20. Hwang A and Muschel RJ: Radiation and the G2 phase of the cell cycle. Radiat Res 150: S52-59, 1998.
21. Nagasawa H, Keng P, Harley R, Dahlberg W and Little JB: Relationship between gamma-ray-induced G2/M delay and cellular radiosensitivity. Int J Radiat Biol 66: 373-379, 1994.
22. Beamish H and Lavin MF: Radiosensitivity in ataxia-telangiectasia - anomalies in radiation-induced cell cycle delay. Int J Radiat Biol 65: 175-184, 1994.
23. Beamish H, Khanna KK and Lavin MF: Ionizing radiation and cell cycle progression in ataxia telangiectasia. Radiat Res 138: 5130-5133, 1994.
24. Lohrer HD: Regulation of the cell cycle following DNA damage in normal and ataxia telangiectasia cells. Experientia 52: 316-328, 1996.
25. Ceraline J, Deplanque G, Duclos B, Limacher JM, Vincent F, Goldblum S and Bergerat JP: Relationships between p53 induction, cell cycle arrest and survival of normal human fibroblasts following DNA damage. Bull Cancer 84: 1007-1016, 1997.
26. Smeets MF, Mooren EH and Begg AC: The effect of radiation on G2 blocks, cyclin B expression and cdc2 expression in human squamous carcinoma cell lines with different radiosensitivities. Radiother Oncol 33: 217-227, 1994.
27. McIlwrath AJ, Vasey PA, Ross GM and Brown R: Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54: 3718-3722, 1994.
28. Siles E, Villalobos M, Valenzuela MT, Nunez MI, Gordon A, McMillan TJ, Pedraza V and Ruiz de Almodovar JM: Relationship between p53 status and radiosensitivity in human tumour cell lines. Br J Cancer 73: 581-588, 1996.
29. Warenius HM, Jones M, Jones MD, Browning PG, Seabra LA and Thompson CCM: Late G(1) accumulation after 2 gy of gamma-irradiation is related to endogenous raf-1 protein expression and intrinsic radiosensitivity in human cells. Br J Cancer 77: 1220-1228, 1998.
30. Bache M, Dunst J, Wurl P, Frode D, Meye A, Schmidt H, Rath FW and Taubert H: G2/m checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines. Anticancer Res 19: 1827-1832, 1999.
31. Chiarugi V, Magnelli L, Cinelli M, Turchetti A and Ruggiero M: Dominant oncogenes, tumor suppressors, and radiosensitivity. Cell Mol Biol Res 41: 161-166, 1995.
32. Schwartz D, Almog N, Peled A, Goldfinger N and Rotter V: Role of wild type p53 in the G(2) phase-regulation of the gamma-irradiation-induced delay and dna repair. Oncogene 15: 2597-2607, 1997.
33. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501, 1998.
34. Winters ZE, Ongkeko WM, Harris AL and Norbury CJ: P53 regulates cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells. Oncogene 17: 673-684, 1998.
35. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B and Liebermann DA: p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 10: 2263-2270, 1995.
36. Pellegata NS, Antoniono RJ, Redpath JL and Stanbridge EJ: DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci USA 93: 15209-15214, 1996.
37. McKenna WG, Bernhard EJ, Markiewicz DA, Rudoltz MS, Maity A and Muschel RJ: Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts: influence of H-ras on the G2 delay. Oncogene 12: 237-245, 1996.